NasdaqGS - Nasdaq Real Time Price USD

LifeStance Health Group, Inc. (LFST)

Compare
6.97 -0.01 (-0.21%)
As of 12:25 PM EDT. Market Open.
Loading Chart for LFST
DELL
  • Previous Close 6.98
  • Open 7.01
  • Bid 6.93 x 100
  • Ask 7.01 x 100
  • Day's Range 6.93 - 7.05
  • 52 Week Range 4.64 - 9.20
  • Volume 329,186
  • Avg. Volume 1,706,292
  • Market Cap (intraday) 2.665B
  • Beta (5Y Monthly) 1.22
  • PE Ratio (TTM) --
  • EPS (TTM) -0.41
  • Earnings Date Aug 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.92

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

lifestance.com

6,984

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LFST

View More

Research Reports: LFST

View More

Performance Overview: LFST

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LFST
11.05%
S&P 500
20.37%

1-Year Return

LFST
2.88%
S&P 500
34.35%

3-Year Return

LFST
55.04%
S&P 500
28.87%

5-Year Return

LFST
65.17%
S&P 500
35.44%

Compare To: LFST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LFST

View More

Valuation Measures

Annual
As of 9/26/2024
  • Market Cap

    2.67B

  • Enterprise Value

    3.08B

  • Trailing P/E

    --

  • Forward P/E

    116.28

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.27

  • Price/Book (mrq)

    1.87

  • Enterprise Value/Revenue

    2.66

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.05%

  • Return on Assets (ttm)

    -2.25%

  • Return on Equity (ttm)

    -10.32%

  • Revenue (ttm)

    1.16B

  • Net Income Avi to Common (ttm)

    -150.92M

  • Diluted EPS (ttm)

    -0.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    86.97M

  • Total Debt/Equity (mrq)

    34.78%

  • Levered Free Cash Flow (ttm)

    86.73M

Research Analysis: LFST

View More

Company Insights: LFST

People Also Watch